Search

everythinglearnresearchcommunity

for

Search:↓

Tissue engineering could be a future solution for hair loss, but it's currently expensive, complex, and hard to apply in real-world treatments.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Cutaneous lymphocytosis in cats is a slowly progressing, relatively benign disease affecting older cats, often causing skin lesions and systemic signs.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

OCT can non-invasively diagnose follicular keratosis and other hair follicle disorders.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Lymphocytic mural folliculitis in cats might be an early sign of pancreatic cancer.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Oral minoxidil can cause inflamed, ingrown hairs in the beard area.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.